IL6 and Hyperglycemia: Our in vivo experimental study supports the role of IL-6 as its levels being elevated in STZ-induced hyperglycemia in male wistar rats and EMPA treated groups shown an amended levels of IL-6, in consistency with other studies both in vivo and in vitro [54, 55].